HOME MAJOR NEEDS SCIENCE PRODUCTS PEOPLE PRESS INVESTORS CAREERS REGION POSTERS AND PUBLICATIONS TECHNOLOGY PIPELINE POSTERS AND PUBLICATIONS PRESENTATIONS 2021 The Academy of Nutrition and Dietetics’ Food and Nutrition Conference & Expo (FNCE) 2021 October 17, 2021 - link AACE 2021 Plenity® Treatment In The Gelesis Loss of Weight (GLOW) Study Was Associated With Improvement In Liver Health, As Measured By The NAFLD Fibrosis Score May 27, 2021 - link Population Health Management COVID-19 and the Urgent Need for New Therapies for Obesity April 23, 2021 - link 2020 Obesity Week 2020 Impaired β-cell Function is Associated with Evidence of Dysfunctional Gut Barrier December 02, 2020 - pdf AASLD 2020 Gelesis Hydrogel Reverses High Fat Diet-Induced Intestinal Alterations and Slows Progression of Hepatic Steatosis in DIO Mice November 13, 2020 - pdf Obesity Week 2020 Evaluating the Interaction of an Oral Superabsorbent Hydrogel with Alcohol and Acidic Beverages November 02, 2020 - pdf Obesity Week 2020 Evaluating Glucose and Insulin as Predictors of Weight Loss in GLOW: A Novel Statistical Approach November 02, 2020 - pdf ECO/ICO 2020 Relevance of intervention with Gelesis100 in overweight and mild obesity: a subgroup analysis of the pivotal GLOW study September 04, 2020 - pdf ECO/ICO 2020 Assessment of the safety and tolerability of Gelesis100 in subjects who reached a body mass index below 27 kg/m2in the pivotal GLOW study September 01, 2020 - pdf ECO/ICO 2020 Comprehensive analysis of safety and tolerability of Gelesis100 in overweight and obesity in the pivotal GLOW study September 01, 2020 - pdf 2019 Obesity Week 2019 Relevance of intervention with Gelesis100 in overweight and mild obesity: a subgroup analysis of the pivotal GLOW study November 04, 2019 - pdf Obesity Week 2019 Assessment of the safety and tolerability of Gelesis100 in subjects who reached a body mass index below 27 kg/m2in the pivotal GLOW study November 04, 2019 - pdf Obesity Week 2019 Comprehensive analysis of safety and tolerability of Gelesis100 in overweight and obesity in the pivotal GLOW study November 04, 2019 - pdf EASL International Liver Congress 2019 GELESIS Superabsorbent Hydrogel Prevents Hepatic Steatosis and Insulin Resistance in High Fat Diet–Induced NAFLD Pre-Clinical Model April 11, 2019 - pdf ENDO 2019 GS300 Novel, Non-Systemic, Superabsorbent Hydrogel Improves Intestinal Barrier Function in Intestinal Injury Pre-Clinical Model March 25, 2019 - pdf 2018 Obesity Journal Editor's Choice A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss November 13, 2018 - link Revue canadienne de physiologie et pharmacologie Effect of a nonsystemic, orally administered hydrogel, GS100, on metformin pharmacokinetics August 01, 2018 - link 2017 European Congress on Obesity Satiety, Weight Loss, and Glycemic Control-Enhancing Properties Vary Between Functional Fibers, Mixed Vegetables, and a Novel Hydrogel (Gelesis200) May 17, 2017 - pdf 2016 Obesity Week Effects of Gelesis200 on fullness and satiety presented at TOS Obesity Week. October 02, 2016 - pdf © 2021 Gelesis – All rights reserved Terms and conditions Privacy Policy E.U. GDPR – English | Italian Social Media Community Guidelines Patent Notice Contact